Wangzhen Shen Selected Research

Wangzhen Shen Research Topics

Disease

15	Epilepsy (Aura) 04/2024 - 11/2005
11	Seizures (Absence Seizure) 04/2024 - 03/2006
10	Epileptic Syndromes 09/2023 - 10/2010
6	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2024 - 10/2010
5	Brain Diseases (Brain Disorder) 01/2024 - 10/2016
4	Febrile Seizures (Febrile Seizure) 04/2024 - 03/2006
3	Generalized Epilepsy 10/2022 - 03/2009
3	Autistic Disorder (Autism) 01/2021 - 12/2020
3	Intellectual Disability (Idiocy) 01/2021 - 12/2020
3	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 03/2009
2	Glioma (Gliomas) 01/2022 - 06/2015
2	Neurodevelopmental Disorders 01/2021 - 01/2021
2	Lennox Gastaut Syndrome 01/2020 - 10/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 10/2010
2	Generalized Epilepsy with Febrile Seizures Plus 10/2010 - 03/2009
1	Inflammation (Inflammations) 10/2023
1	Cognitive Dysfunction 10/2023
1	Undiagnosed Diseases 10/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Autism Spectrum Disorder 12/2020
1	Neuroinflammatory Diseases 10/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2017
1	Ventricular Tachycardia 04/2017
1	Oculocutaneous albinism type 2 12/2016
1	Glioblastoma (Glioblastoma Multiforme) 06/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2009

Drug/Important Bio-Agent (IBA)

11	Aminobutyrates (Aminobutyric Acid)IBA 01/2024 - 04/2014
6	GABA Plasma Membrane Transport ProteinsIBA 09/2023 - 10/2019
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2010
6	gamma-Aminobutyric Acid (GABA)IBA 10/2022 - 04/2014
6	GABA-A Receptors (GABA(A) Receptor)IBA 11/2017 - 11/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2023 - 07/2015
3	Ion Channels (Ion Channel)IBA 10/2022 - 07/2015
3	Nonsense Codon (Nonsense Mutation)IBA 10/2016 - 10/2010
2	Protein Subunits (Protein Subunit)IBA 04/2024 - 09/2023
2	Mutant Proteins (Protein, Mutant)IBA 04/2024 - 10/2020
2	4-phenylbutyric acid (Buphenyl)FDA Link 09/2023 - 01/2022
2	Peptides (Polypeptides)IBA 01/2017 - 02/2013
2	Messenger RNA (mRNA)IBA 12/2016 - 03/2009
2	Sodium Channels (Sodium Channel)IBA 03/2009 - 03/2006
1	Zonisamide (Zonegran)FDA LinkGeneric 04/2024
1	Phenobarbital (Luminal)FDA Link 11/2023
1	ginsenoside Rg1IBA 10/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2023
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Sincalide FDA Link 01/2022
1	BerberineIBA 01/2022
1	EnzymesIBA 10/2020
1	ImmunosorbentsIBA 10/2020
1	CytokinesIBA 10/2020
1	CannabinoidsIBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017
1	MacrolidesIBA 04/2017
1	Pentylenetetrazole (Metrazol)IBA 01/2017
1	ConvulsantsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 12/2016
1	MitogensIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Ligand-Gated Ion ChannelsIBA 04/2014
1	Codon (Codons)IBA 02/2013
1	3' Untranslated Regions (3' UTR)IBA 02/2013
1	Terminator Codon (Termination Codon)IBA 03/2009
1	Aspartic Acid (Aspartate)FDA Link 11/2005

Therapy/Procedure

2	Therapeutics 01/2016 - 07/2015